OpenAI Signals $1T IPO Race to Beat Anthropic 2026

OpenAI confidentially filed its draft IPO prospectus in late May 2026, becoming the first company valued above $850 billion in private markets to pursue a public listing in US history. Seven days later, its primary rival Anthropic filed its own S-1. Two companies together worth roughly $1.8 trillion in private market transactions are now racing toward public exchanges that have never priced assets quite like them: organizations that are simultaneously the most commercially important technology developers on the planet and the most actively studied potential sources of catastrophic risk.

What Actually Happened

OpenAI submitted a confidential draft prospectus to the SEC around May 22, 2026, with Goldman Sachs and Morgan Stanley serving as lead advisers on the offering. The company is targeting a Q4 2026 public listing at approximately $1 trillion valuation, a number that would make it the largest technology IPO in history by multiple measures, surpassing the $2.1 trillion at which Saudi Aramco listed in 2019. OpenAI's revenue trajectory supports the ambition: the company crossed $14 billion in annualized revenue at the close of its February Series H, and internal projections shared with early-stage investors indicate that number has grown materially through spring 2026. The confidential filing means the full prospectus, with detailed unit economics and risk factors, has not yet entered the public record.

Anthropic's S-1 filing, submitted June 1, creates a direct head-to-head IPO race for the first time in this industry's history. Anthropic is targeting an initial valuation of approximately $965 billion, derived from its most recent primary funding round led by Lightspeed Venture Partners, with contributions from Google, Amazon, and Salesforce Ventures. Anthropic reported run-rate revenue crossing $47 billion annually at the Series H close, a figure that represents one of the fastest revenue-scaling trajectories ever recorded for a software company at this valuation level. The IPO race is not just symbolic: institutional investors who want exposure to leading AI labs will be forced to choose how to allocate capital between the two offerings, and the company that prices its IPO first will set the benchmark against which the second company is measured, at the moment when benchmark-setting carries the most pricing power.

Both filings are complicated by the active negotiations between the Trump administration and OpenAI over a potential US government equity stake. Trump publicly stated on June 6 that the government "may take direct equity stakes" in OpenAI, Anthropic, and xAI, framing it as the public becoming "a partner in this revolution." The mechanics of how such a stake would be structured within a public company, including whether it would carry special voting rights, how it would affect the IPO price discovery process, and whether it would require separate congressional authorization, are unresolved. SEC disclosure requirements for companies with government equity stakes are rare enough that legal precedent for this specific structure barely exists in modern securities law. Both companies have filed confidentially in part to resolve these structural questions before the prospectus enters the public record.

Why This Matters More Than People Think

The AI industry has operated in a valuation vacuum since ChatGPT launched in November 2022. Private market valuations for AI companies, while enormous, are set by a handful of sophisticated investors in rounds structured to protect downside while maximizing upside through liquidation preferences and anti-dilution provisions. Public markets are fundamentally different: every analyst, every portfolio manager, and every individual investor can form an opinion on what OpenAI or Anthropic is worth, and the market's aggregate judgment is expressed in a share price updated thousands of times per second. The IPO doesn't just provide OpenAI and Anthropic with employee liquidity. It creates a publicly visible, continuously updated, globally observable answer to the question "how much is frontier AI worth?" That answer will cascade through every AI startup's next funding round, every VC portfolio's carry calculation, and every corporate AI investment budget in the world within weeks of the first IPO pricing.

The revenue multiples at which these companies price will set the comparable transactions for three years of AI fundraising and M&A. If OpenAI lists at 70x forward revenue, a multiple aggressive but defensible for a company at the frontier of a genuine platform-level technology shift, every AI startup's next funding round will be benchmarked against that multiple. If it lists at 20x, closer to the mature SaaS multiples that public markets have historically applied to recurring revenue software businesses, the air will exit private AI valuations within a month of the pricing. The effect on venture capital allocation to AI, which captured 33% of all US venture dollars in 2026 according to PitchBook data, would be immediate, observable, and industry-reshaping. Public market AI comparable transactions are the single most important pricing signal the global venture capital industry does not yet have, and it's about to receive them simultaneously from the two most important companies in the sector.

The government equity stake question adds a variable that Wall Street has never fully modeled for technology companies in the modern era. Norway's Government Pension Fund owns equity in virtually every large-cap public company globally, but as a passive financial investor with no governance rights. A government holding an equity stake tied to explicit oversight rights and board representation in an AI company is structurally different from any precedent in modern US securities markets. If the government's stake includes any preferential voting rights, board seats, or information access that other shareholders don't receive, the SEC disclosure requirements become unusually complex and potentially require no-action letter guidance that the agency has never issued. The lawyers advising Goldman and Morgan Stanley are reportedly working through a disclosure framework with no direct precedent in securities law as it currently stands.

The Competitive Landscape

The companies most immediately affected by the OpenAI and Anthropic IPOs are their direct competitors who will remain private for the near term. Google's Gemini division and Meta's AI research group are already embedded in public companies, with their AI investment priced through quarterly earnings calls. Microsoft, which has the deepest OpenAI integration through its Copilot product line across Office, Windows, and Azure, will see its own AI investment narrative pressure-tested against OpenAI's public disclosures in ways that will make Microsoft earnings calls more complicated for the foreseeable future. The smaller AI labs operating at billion-dollar valuations, the ones that have not crossed into the multi-hundred-billion tier, are in the most precarious position: when OpenAI's public prospectus discloses detailed unit economics, compute costs per training run, and revenue concentration by customer type, every investor in every smaller AI company will ask whether the smaller company's business model can achieve similar economics at scale.

The historical parallel that the AI IPO race most closely resembles is the search engine era IPO of the early 2000s, specifically Google's 2004 public offering. Google went public at $85 per share through a Dutch auction structure designed to resist Wall Street's traditional IPO underpricing, raised $1.9 billion at a market cap that seemed richly valued at the time, and ultimately proved to be one of the most mispriced assets in technology history. The parallel isn't in the numerical comparison but in the market's structural uncertainty about how to value a genuinely transformative technology at the moment of first public pricing. Google's pre-IPO competitors, Yahoo and MSN, were established businesses the market understood from prior earnings history. The question of how to value a company that might reshape every industry's fundamental economics was new then. OpenAI and Anthropic face the same fundamental uncertainty, multiplied by the safety and governance questions that Google never had to address on a roadshow.

The bear case for both IPOs is not speculative or theoretical. OpenAI and Anthropic are spending enormous sums on compute infrastructure, with training costs for frontier models scaling superlinearly with capability. OpenAI's training costs for GPT-5 were reported at approximately $500 million, and the next generation of models will cost more. Anthropic's training infrastructure relies on Google's TPUs and Amazon's Trainium chips at negotiated rates that may not remain favorable as competing demand from other AI companies increases. Both companies face the structural possibility that frontier model development becomes so capital-intensive that profitability at the margins expected by public equity investors is not achievable in the near term, creating a tension between the mission-driven framing of the S-1 narrative and the return expectations of institutional shareholders. The comparison to cloud infrastructure companies, which spent years burning cash before achieving sustainable operating margins, offers some historical comfort. But cloud infrastructure had predictable per-unit cost curves that declined reliably with scale. AI model development has cost curves that no one can predict reliably beyond two training generations.

Hidden Insight: Public Markets Force the Safety Accountability Problem

AI safety research has, until now, been governed by internal norms, board decisions made by people who share professional networks and investment relationships, and occasional public statements timed for maximum PR impact rather than maximum transparency. Public company status changes that accountability structure permanently and in ways that AI lab leadership has not fully reckoned with publicly. Every quarter, OpenAI and Anthropic will face analyst questions about the ratio of safety research spending to commercial product development velocity. Every earnings call becomes a public record. Every safety incident, model capability release decision, and choice to defer a safety benchmark becomes a potential disclosure question for the CFO and CEO on calls that can be replayed, quoted in litigation, and referenced in regulatory proceedings for years.

This accountability mechanism cuts in unexpected directions. On one hand, public disclosure requirements make safety spending visible and therefore measurable and comparable. If Anthropic claims to allocate 30% of its operating budget to alignment research, that number will be in the annual report, subject to audit, and comparable year-over-year by any analyst. Commitment to safety research that currently exists as a cultural norm becomes a disclosed financial line item that investors can track. On the other hand, public companies optimize for metrics that affect share prices over quarterly cycles. If safety research doesn't produce quarterly revenue, and it rarely does in the near term, the incentive structure for a public company creates systematic pressure to underspend on safety relative to a private company that can ignore shareholder pressure for returns. The track record of public companies maintaining commitments to long-term, commercially unrewarding capital expenditures against short-term earnings pressure is not uniformly encouraging across industries or time periods.

There's a second-order talent effect that no one is yet fully modeling in public: compensation structures. The best AI safety researchers are largely working at AI labs rather than universities because the compute resources and compensation at the labs are unmatched in academia. Public company status will change the compensation structure at OpenAI and Anthropic, replacing the non-dilutive equity arrangements and mission-aligned benefit structures that have been used to retain researchers with standard public company option grants that vest on commercial schedules and are measured against stock price performance. If researchers who chose their role for mission-alignment reasons find the public company incentive structure less coherent with their values, they'll leave for academic safety institutes or for the next wave of private AI companies. That talent shift, if it occurs, will happen slowly enough to be invisible on quarterly earnings calls but fast enough to materially change the direction of safety research over a five-year horizon.

The most counterintuitive outcome of the AI IPO wave may be that it strengthens rather than weakens the political case for external intervention in AI development. Public company disclosures will make the safety spending levels, governance structures, capability roadmaps, and unit economics of leading AI labs publicly visible for the first time. If those disclosures reveal that commercial incentives are producing safety research investment below what researchers themselves assess as necessary, the argument for mandatory government oversight will be backed by financial data rather than theoretical risk. The Sanders bill's 50% stake proposal and the Trump administration's voluntary equity framework will both become stronger arguments if the first AI IPO prospectuses show that frontier AI development is systematically underinvesting in safety relative to capability. The quarterly earnings call, paradoxically, may be the most effective AI safety accountability mechanism ever created, not because it enforces safety directly, but because it makes the tradeoff between safety and commercial returns observable to everyone simultaneously.

What to Watch Next

The 30-day timeline is dominated by preparation for the public S-1 filings, expected in August or September if OpenAI is targeting a Q4 debut. When those prospectuses go public, the key disclosures to watch are: revenue growth rate on a quarterly basis (not annualized), compute cost per model-output token (an efficiency metric that tells you whether unit economics are improving with scale), and the breakdown between consumer ChatGPT subscription revenue and API-plus-enterprise revenue. Enterprise API revenue is higher margin and more predictable from an investor perspective; if it's growing faster than consumer subscriptions, the valuation-at-multiple argument is stronger for institutional buyers. Also watch the language around the government equity stake, which will likely appear as a risk factor rather than a confirmed structural term until the SEC completes its review of whatever ownership framework the lawyers devise.

By 90 days, the roadshows will be underway. AI industry executives rarely appear before institutional investor audiences to take unscripted questions about model capabilities, safety trade-offs, compute cost trajectories, and competitive dynamics. The roadshow circuit will be the first time Sam Altman and Dario Amodei face the full weight of sophisticated public-market investor scrutiny, under conditions where every statement is legally on the record and can be cited in securities fraud proceedings. Sovereign wealth funds from Norway, Singapore, the Middle East, and Canada, which have the largest AI-sector investment mandates among institutional allocators globally, will be among the most influential participants in the book-building process. Their pricing bids will set the IPO price as much as Goldman's and Morgan Stanley's fairness analysis will, and their questions will define what AI accountability means in a public-company context.

The 180-day signal to watch is the first post-IPO quarterly earnings call for whichever company goes public first. That call will establish what AI public company accountability actually looks like in practice under real market pressure. If analysts push hard on safety metrics and receive substantive, financially grounded answers, it will set a disclosure precedent that the entire AI industry will have to follow in subsequent filings. If the call is dominated by standard SaaS growth metrics, user counts, and API call volumes with safety treated as a one-paragraph boilerplate disclosure, it will signal that the public markets don't intend to hold AI companies to any different standard than conventional software businesses. The answer to that question will shape the regulatory environment for AI for the remainder of the decade, because it will tell policymakers whether market accountability is sufficient or whether mandatory oversight frameworks are necessary to fill the gap.

The AI industry has been setting its own safety standards in private, accountable to investors who chose to be there. Public markets will make those standards visible, auditable, and priced into every share that trades.

---